Dr. Robert Gerszten is Director of Translational Research in the Cardiology Division at the Massachusetts General Hospital. He is also Associate Professor of Medicine at Harvard Medical School and a Senior Associate at the Broad Institute of Harvard and MIT.
Dr. Gerszten’s research efforts have focused on understanding the molecular basis of inflammation and wound healing in cardiovascular disease. Investigation in his group spans from the bench to the bedside. His laboratory has incorporated emerging proteomics and metabolomics technologies to help identify novel signals derived from leukocytes, endothelial cells, or from the myocardium. In ongoing translational studies, he applies these same methodologies directly to samples from well-phenotyped human cohorts to identify candidate biomarkers. The research incorporates basic molecular and cell biology, chemistry and mass spectrometry, bioinformatics, and clinical investigation.
He is chairman of the National Institutes of Health Clinical Proteomics Centers and also serves on the Cardiovascular Disease Steering Committee for the Human Proteome Organization.